Loring Wolcott & Coolidge Fiduciary Advisors LLP Merck & Co., Inc. Transaction History
Loring Wolcott & Coolidge Fiduciary Advisors LLP
- $10.4 Billion
- Q1 2024
A detailed history of Loring Wolcott & Coolidge Fiduciary Advisors LLP transactions in Merck & Co., Inc. stock. As of the latest transaction made, Loring Wolcott & Coolidge Fiduciary Advisors LLP holds 421,819 shares of MRK stock, worth $53.2 Million. This represents 0.53% of its overall portfolio holdings.
Number of Shares
421,819
Previous 427,090
1.23%
Holding current value
$53.2 Million
Previous $46.6 Million
19.54%
% of portfolio
0.53%
Previous 0.47%
Shares
29 transactions
Others Institutions Holding MRK
# of Institutions
3,771Shares Held
1.87BCall Options Held
17.3MPut Options Held
14.8M-
Vanguard Group Inc Valley Forge, PA243MShares$30.7 Billion0.65% of portfolio
-
Black Rock Inc. New York, NY207MShares$26.1 Billion0.65% of portfolio
-
State Street Corp Boston, MA117MShares$14.8 Billion0.7% of portfolio
-
Wellington Management Group LLP Boston, MA86.3MShares$10.9 Billion2.07% of portfolio
-
Geode Capital Management, LLC Boston, MA56.4MShares$7.11 Billion0.7% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $319B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...